0001209191-20-037948.txt : 20200619
0001209191-20-037948.hdr.sgml : 20200619
20200619163723
ACCESSION NUMBER: 0001209191-20-037948
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200617
FILED AS OF DATE: 20200619
DATE AS OF CHANGE: 20200619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BALTIMORE DAVID
CENTRAL INDEX KEY: 0001185858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 20976109
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-17
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001185858
BALTIMORE DAVID
C/O REGULUS THERAPEUTICS INC.
10628 SCIENCE CENTER DR., #225
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (Right to Buy)
0.88
2020-06-17
4
A
0
23250
0.00
A
2030-06-16
Common Stock
23250
23250
D
Pursuant to the Company's Non Employee Director's Compensation policy, the options are automatically granted on the date of the Company's Annual Meeting of Stockholders and will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the Company's next annual stockholder meeting, whichever occurs first, subject to the Reporting Person's continuous service.
Christopher Aker, Attorney in Fact
2020-06-19